Home
About
Science
Pipeline
Clinical Trials
Partnerships
Investors
News

Investors | Largest Shareholders

Home InvestorsLargest Shareholders

Investors | Largest Shareholders

Investors

Overview
The Share
Shareholder Information
Nomination Committee
Largest Shareholders
Financial Calendar
Events
Analyst Coverage
IR Contact
National Prospectus 2026

Oncolytic Molecules that Kill Cancer with Direct & Abscopal Tumor Effects

Oslo, Norway

Company

About
Management Team
Board of Directors
Scientific Advisory Board

Science

Our Science
Pipeline
Publications
Posters

Resources

Clinical Trials
News & Events
Investor Relations

Connect

Partnerships
Contact

Partner With Us

© 2026 Lytix Biopharma AS. All rights reserved.

Privacy PolicyTerms and Conditions Disclaimer